Terms: = Lung cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Staging
16 results:
1. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
Li J; Wang YC; Lin JY
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
[No Abstract] [Full Text] [Related]
2. Mediastinal lymph node removal modulates natural killer cell exhaustion in patients with non-small cell lung cancer.
Cikman DI; Esen F; Engin A; Turna A; Agkoc M; Yilmaz A; Saglam OF; Deniz G; Aktas EC
Immunol Res; 2023 Dec; 71(6):959-971. PubMed ID: 37583002
[TBL] [Abstract] [Full Text] [Related]
3. Transcriptomics in Tumor and Normal lung Tissues Identify Patients With Early-Stage Non-Small-Cell lung cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies.
Lazar V; Girard N; Raymond E; Martini JF; Galbraith S; Raynaud J; Bresson C; Solomon B; Magidi S; Nechushtan H; Onn A; Berger R; Chen H; Al-Omari A; Ikeda S; Lassen U; Sekacheva M; Felip E; Tabernero J; Batist G; Spatz A; Pramesh CS; Girard P; Blay JY; Philip T; Berindan-Neagoe I; Porgador A; Rubin E; Kurzrock R; Schilsky RL
JCO Precis Oncol; 2022 Sep; 6():e2200072. PubMed ID: 36108261
[TBL] [Abstract] [Full Text] [Related]
4. Mediastinal lymph node removal ameliorates cytotoxic T-lymphocyte functions in patients with non-small cell lung cancer.
Engin A; Turna A; Esen F; Agkoc M; Cikman DI; Saglam OF; Deniz G; Aktas EC
Tumori; 2023 Feb; 109(1):97-104. PubMed ID: 34918599
[TBL] [Abstract] [Full Text] [Related]
5. Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC.
Gauvin C; Krishnan V; Kaci I; Tran-Thanh D; Bédard K; Albadine R; Leduc C; Gaboury L; Blais N; Tehfe M; Routy B; Florescu M
Curr Oncol; 2021 Jan; 28(1):593-605. PubMed ID: 33498159
[TBL] [Abstract] [Full Text] [Related]
6. Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell lung cancer: Safety and Immunologic Activity.
Predina JD; Haas AR; Martinez M; O'Brien S; Moon EK; Woodruff P; Stadanlick J; Corbett C; Frenzel-Sulyok L; Bryski MG; Eruslanov E; Deshpande C; Langer C; Aguilar LK; Guzik BW; Manzanera AG; Aguilar-Cordova E; Singhal S; Albelda SM
Mol Ther; 2021 Feb; 29(2):658-670. PubMed ID: 33160076
[TBL] [Abstract] [Full Text] [Related]
7. [Small-cell lung cancer: epidemiology, diagnostics and therapy].
Pešek M; Mužík J
Vnitr Lek; 2018; 63(11):876-883. PubMed ID: 29303289
[TBL] [Abstract] [Full Text] [Related]
8. Radiological manifestations of immune-related adverse effects observed in patients with melanoma undergoing immunotherapy.
Sidhu P; Menzies AM; Long G; Carlino M; Lorens S; Kapoor R
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):759-766. PubMed ID: 29024572
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.
Rossi S; Toschi L; Castello A; Grizzi F; Mansi L; Lopci E
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2310-2325. PubMed ID: 28815334
[TBL] [Abstract] [Full Text] [Related]
10. The Mesenchymal State Predicts Poor Disease-Free Survival in Resectable Non-Small Cell lung cancer.
Mehta K; Moravcikova E; McFall D; Luketich JD; Pennathur A; Donnenberg AD; Donnenberg VS
Ann Thorac Surg; 2017 Jul; 104(1):321-328. PubMed ID: 28499650
[TBL] [Abstract] [Full Text] [Related]
11. The impact of geographic unit of analysis on socioeconomic inequalities in cancer survival and distant summary stage - a population-based study.
Tervonen HE; Morrell S; Aranda S; Roder D; You H; Niyonsenga T; Walton R; Baker D; Currow D
Aust N Z J Public Health; 2017 Apr; 41(2):130-136. PubMed ID: 27960223
[TBL] [Abstract] [Full Text] [Related]
12. Estimation of the pathological invasive size of pulmonary adenocarcinoma using high-resolution computed tomography of the chest: A consideration based on lung and mediastinal window settings.
Sakakura N; Inaba Y; Yatabe Y; Mizuno T; Kuroda H; Yoshimura K; Sakao Y
Lung Cancer; 2016 May; 95():51-6. PubMed ID: 27040852
[TBL] [Abstract] [Full Text] [Related]
13. [The level of soluble programmed death-1 in peripheral blood of patients with lung cancer and its clinical implications].
Xing YF; Zhang ZL; Shi MH; Ma Y; Chen YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):102-6. PubMed ID: 22455965
[TBL] [Abstract] [Full Text] [Related]
14. [Significance of caveolin-1 protein detected by quantum dots technique in human lung cancer invasiveness and metastasis.].
Chen HL; Zhang YX; Xue JL; Yu BP
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Nov; 32(11):821-4. PubMed ID: 20079291
[TBL] [Abstract] [Full Text] [Related]
15. [Morphometric intratumoral microvessel area evaluation could be a useful indicator for coadjuvant therapy in ressected NSCLC].
Irion LC; Prolla JC; Hartmann AA; da Silva VD
Rev Port Pneumol; 2003; 9(1):19-32. PubMed ID: 12958665
[TBL] [Abstract] [Full Text] [Related]
16. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients.
Rinne D; Baum RP; Hör G; Kaufmann R
Cancer; 1998 May; 82(9):1664-71. PubMed ID: 9576286
[TBL] [Abstract] [Full Text] [Related]
